
Cassava Sciences is a biotechnology business based in the US. Cassava Sciences shares (SAVA) are listed on the NASDAQ and all prices are listed in US Dollars. Cassava Sciences employs 26 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Cassava Sciences stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SAVA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Cassava Sciences stock price (NASDAQ: SAVA)
Use our graph to track the performance of SAVA stocks over time.Cassava Sciences shares at a glance
Latest market close | $26.15 |
---|---|
52-week range | $13.84 - $51.59 |
50-day moving average | $28.43 |
200-day moving average | $30.28 |
Wall St. target price | $84.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.93 |
Buy Cassava Sciences stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Cassava Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cassava Sciences price performance over time
Historical closes compared with the close of $26.15 from 2023-03-20
1 week (2023-03-15) | 0.38% |
---|---|
1 month (2023-02-22) | 3.61% |
3 months (2022-12-21) | -29.11% |
6 months (2022-09-22) | -48.79% |
1 year (2022-03-18) | N/A |
---|---|
2 years (2021-03-22) | -53.14% |
3 years (2020-03-20) | 575.71% |
5 years (2018-03-21) | 276.26% |
Cassava Sciences financials
Gross profit TTM | $-68,032,000 |
---|---|
Return on assets TTM | -19.94% |
Return on equity TTM | -31.67% |
Profit margin | 0% |
Book value | $5.45 |
Market capitalisation | $1.1 billion |
TTM: trailing 12 months
Cassava Sciences share dividends
We're not expecting Cassava Sciences to pay a dividend over the next 12 months.
Have Cassava Sciences's shares ever split?
Cassava Sciences's shares were split on a 1:7 basis on 9 May 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cassava Sciences shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Cassava Sciences shares which in turn could have impacted Cassava Sciences's share price.
Cassava Sciences share price volatility
Over the last 12 months, Cassava Sciences's shares have ranged in value from as little as $13.84 up to $51.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cassava Sciences's is -0.0922. This would suggest that Cassava Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cassava Sciences has bucked the trend.
Cassava Sciences overview
Cassava Sciences, Inc. , a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Cassava Sciences in the news
3 Short-Squeeze Stocks to Keep on Your Radar

Cassava Sciences stock price outlook is bearish despite insider buy
Cassava Sciences, Inc. (NASDAQ:SAVA) Has Found A Path To Profitability
Frequently asked questions
What percentage of Cassava Sciences is owned by insiders or institutions?Currently 7.686% of Cassava Sciences shares are held by insiders and 27.342% by institutions. How many people work for Cassava Sciences?
Latest data suggests 26 work at Cassava Sciences. When does the fiscal year end for Cassava Sciences?
Cassava Sciences's fiscal year ends in December. Where is Cassava Sciences based?
Cassava Sciences's address is: 7801 North Capital of Texas Highway, Austin, TX, United States, 78731 What is Cassava Sciences's ISIN number?
Cassava Sciences's international securities identification number is: US14817C1071 What is Cassava Sciences's CUSIP number?
Cassava Sciences's Committee on Uniform Securities Identification Procedures number is: 14817C107
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert